Ubs Group Ag Cryo Cell International Inc Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Cryo Cell International Inc stock. As of the latest transaction made, Ubs Group Ag holds 249 shares of CCEL stock, worth $2,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
249Holding current value
$2,104% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding CCEL
# of Institutions
16Shares Held
920KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$3.46 Million2.79% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.4 Million0.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA117KShares$987,3650.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$938,2450.02% of portfolio
-
Geode Capital Management, LLC Boston, MA39.9KShares$336,8170.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $72M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...